These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17599785)

  • 1. Donepezil in Alzheimer's disease: a clinical observational study evaluating individual treatment response.
    Riepe MW; Kohler J; Horn R
    Curr Med Res Opin; 2007 Aug; 23(8):1829-35. PubMed ID: 17599785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of donepezil over 3 years: an open-label, multicentre study in patients with Alzheimer's disease.
    Burns A; Gauthier S; Perdomo C
    Int J Geriatr Psychiatry; 2007 Aug; 22(8):806-12. PubMed ID: 17199235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donepezil treatment of severe Alzheimer's disease in nursing home settings. A responder analysis.
    Jelic V; Haglund A; Kowalski J; Langworth S; Winblad B
    Dement Geriatr Cogn Disord; 2008; 26(5):458-66. PubMed ID: 18984956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of age on response to rivastigmine or donepezil in patients with Alzheimer's disease.
    Bullock R; Bergman H; Touchon J; Gambina G; He Y; Nagel J; Lane R
    Curr Med Res Opin; 2006 Mar; 22(3):483-94. PubMed ID: 16574032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term safety and efficacy of donepezil in patients with severe Alzheimer's disease: results from a 52-week, open-label, multicenter, extension study in Japan.
    Homma A; Imai Y; Tago H; Asada T; Shigeta M; Iwamoto T; Takita M; Arimoto I; Koma H; Takase T; Ohbayashi T
    Dement Geriatr Cogn Disord; 2009; 27(3):232-9. PubMed ID: 19246907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive, global, and functional benefits of donepezil in Alzheimer's disease and vascular dementia: results from large-scale clinical trials.
    Passmore AP; Bayer AJ; Steinhagen-Thiessen E
    J Neurol Sci; 2005 Mar; 229-230():141-6. PubMed ID: 15760632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific symptomatic changes following donepezil treatment of Alzheimer's disease: a multi-centre, primary care, open-label study.
    Rockwood K; Black S; Bedard MA; Tran T; Lussier I;
    Int J Geriatr Psychiatry; 2007 Apr; 22(4):312-9. PubMed ID: 17006874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Post-marketing observational study of donepezil].
    Ibach B
    Krankenpfl J; 2005; 43(1-3):25. PubMed ID: 15912820
    [No Abstract]   [Full Text] [Related]  

  • 9. Donepezil in Alzheimer's disease: what to expect after 3 years of treatment in a routine clinical setting.
    Wallin AK; Andreasen N; Eriksson S; Båtsman S; Nasman B; Ekdahl A; Kilander L; Grut M; Rydén M; Wallin A; Jonsson M; Olofsson H; Londos E; Wattmo C; Eriksdotter Jonhagen M; Minthon L;
    Dement Geriatr Cogn Disord; 2007; 23(3):150-60. PubMed ID: 17312368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of open-label donepezil treatment in patients with Alzheimer's disease discontinuing memantine monotherapy.
    Sakka P; Tsolaki M; Hort J; Hager K; Soininen H; López Pousa S; Li C; Schwam E
    Curr Med Res Opin; 2007 Dec; 23(12):3153-65. PubMed ID: 17988434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of ApoE genotype on response to donepezil in patients with Alzheimer's disease.
    Choi SH; Kim SY; Na HR; Kim BK; Yang DW; Kwon JC; Park MY
    Dement Geriatr Cogn Disord; 2008; 25(5):445-50. PubMed ID: 18401173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of donepezil in early-stage Alzheimer disease: a randomized placebo-controlled trial.
    Seltzer B; Zolnouni P; Nunez M; Goldman R; Kumar D; Ieni J; Richardson S;
    Arch Neurol; 2004 Dec; 61(12):1852-6. PubMed ID: 15596605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donepezil treatment and Alzheimer disease: can the results of randomized clinical trials be applied to Alzheimer disease patients in clinical practice?
    Tinklenberg JR; Kraemer HC; Yaffe K; Ross L; Sheikh J; Ashford JW; Yesavage JA; Taylor JL
    Am J Geriatr Psychiatry; 2007 Nov; 15(11):953-60. PubMed ID: 17974866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No donepezil discontinuation effect in patients with Alzheimer's disease who were switched to rivastigmine after failing to benefit from donepezil treatment.
    Auriacombe S; Pere JJ;
    Curr Med Res Opin; 2003; 19(8):715-7. PubMed ID: 14687442
    [No Abstract]   [Full Text] [Related]  

  • 15. Donepezil for Alzheimer's disease.
    Benjamin B; Burns A
    Expert Rev Neurother; 2007 Oct; 7(10):1243-9. PubMed ID: 17939763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results, rhetoric, and randomized trials: the case of donepezil.
    Gilstad JR; Finucane TE
    J Am Geriatr Soc; 2008 Aug; 56(8):1556-62. PubMed ID: 18662199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Verbal repetition in patients with Alzheimer's disease who receive donepezil.
    Asp E; Cloutier F; Fay S; Cook C; Robertson ML; Fisk J; Dei DW; Rockwood K
    Int J Geriatr Psychiatry; 2006 May; 21(5):426-31. PubMed ID: 16676290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donepezil for cognitive decline following coronary artery bypass surgery: a pilot randomized controlled trial.
    Doraiswamy PM; Babyak MA; Hennig T; Trivedi R; White WD; Mathew JP; Newman MF; Blumenthal JA
    Psychopharmacol Bull; 2007; 40(2):54-62. PubMed ID: 17514186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with donepezil in Alzheimer patients with and without cerebrovascular disease.
    Frölich L; Klinger T; Berger FM
    J Neurol Sci; 2002 Nov; 203-204():137-9. PubMed ID: 12417372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donepezil treatment of patients with severe Alzheimer's disease in a Japanese population: results from a 24-week, double-blind, placebo-controlled, randomized trial.
    Homma A; Imai Y; Tago H; Asada T; Shigeta M; Iwamoto T; Takita M; Arimoto I; Koma H; Ohbayashi T
    Dement Geriatr Cogn Disord; 2008; 25(5):399-407. PubMed ID: 18391486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.